Improving patient SAFETY through better methods of clinical risk management
Looptijd
06 / 2008 - 12 / 2011
Status
Afgesloten
Onderzoeknummer
OND1326798
Leverancier gegevens
Website TI Pharma
Samenvatting (EN)
Aim : Develop risk minimization model to address the most common adverse drug events in T2DM, heart failure, and arrhythmia. Implementation of the model of risk minimization in practice.
